Xiangjin Zheng

Chinese PLA General Hospital — China

Medicine · Health Sciences

23h-index2.3kcitations42works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ferroptosis and cancer prognosis(9), Cancer, Lipids, and Metabolism(7), MicroRNA in disease regulation(6), FOXO transcription factor regulation(6), RNA modifications and cancer(5)

Publications42 total

Chinese population may require further venetoclax dose reduction beyond guidelines when combined with voriconazole: real-world evidence from China
Frontiers in Pharmacology·2025Open Access
Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/ FOXO1 pathway
Clinical Epigenetics·2024· 1 citedOpen Access
Correction: MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
Signal Transduction and Targeted Therapy·2024· 1 citedOpen Access
Author Correction: ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway
Acta Pharmacologica Sinica·2024· 1 citedOpen Access
Corrigendum to “Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis” [Pharmacol. Res. 2022 Sep:183:106376]
Pharmacological Research·2024Open Access
Corrigendum to “Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence” [Pharmacol. Res. 181 (2022), 106259]
Pharmacological Research·2024Open Access
Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis
Acta Pharmacologica Sinica·2024· 1 citedOpen Access
Author correction to ‘3-O-Acetyl-11-keto-β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma’ [Acta Pharm Sin B 10 (2020) 301–312]
Acta Pharmaceutica Sinica B·2024Open Access
CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
Journal of Translational Medicine·2022· 105 citedOpen Access
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways
Acta Pharmaceutica Sinica B·2022· 62 citedOpen Access
Author Correction: Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis
Acta Pharmacologica Sinica·2022· 9 citedOpen Access
Author Correction: Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle
Acta Pharmacologica Sinica·2022· 4 citedOpen Access
Correction: 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase
Journal of Experimental & Clinical Cancer Research·2022· 1 citedOpen Access
Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis
Pharmacological Research·2022· 89 citedOpen Access
Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway
Clinical Epigenetics·2022Open Access
Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis
Acta Pharmacologica Sinica·2022· 74 citedOpen Access
Anti-tumor effects of Skp2 inhibitor AAA-237 on NSCLC by arresting cell cycle at G0/G1 phase and inducing senescence
Pharmacological Research·2022· 29 citedOpen Access
ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway
Acta Pharmacologica Sinica·2022· 66 citedOpen Access
GABRP is a potential prognostic biomarker and correlated with immune infiltration and tumor microenvironment in pancreatic cancer
Translational Cancer Research·2022· 14 citedOpen Access
Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle
Acta Pharmacologica Sinica·2021· 76 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jinhua Wang(39), Guanhua Du(39), Liwen Ren(38), Jinyi Liu(34), Weiqi Fu(23), Yihui Yang(19), Li Wan(14), Wan Li(11), Sha Li(10), Binbin Ge(10), Yizhi Zhang(9), Jie Yi(8), Shiwei Liu(6), Li Wan(6), Tengfei Ji(5), Xiaocong Pang(4), Sha Li(4), Hong Yang(4), Jie Yi(4), Qin Tang(3)